🎯 check Cobimetinib (GDC-0973) product page
Cobimetinib (GDC-0973) is a potent MEK1/MEK2 inhibitor. It blocks the MAPK signaling pathway by decreasing ERK phosphorylation and inducing PARP cleavage, effectively inhibiting tumor cell proliferation and promoting apoptosis.